Literature DB >> 20217594

Fluorescent silica nanoparticles for cancer imaging.

Swadeshmukul Santra1.   

Abstract

In recent years, fluorescent silica nanoparticles (FSNPs) received immense interest in cancer imaging. FSNPs are a new class of engineered optical probes consisting of silica NPs loaded with fluorescent dye molecules. These probes exhibit some attractive features, such as photostability and brightness, which allow sensitive imaging of cancer cells. In general, FSNPs are chemically synthesized in solution using appropriate silane-based precursors. Fluorescent dye molecules are entrapped during the synthesis process. The synthetic process involves hydrolysis and condensation reactions of silane precursors. Stöber's sol-gel and water-in-oil (W/O) microemulsion methods are two popular chemical methods that have been used for synthesizing FSNPs. Silica matrix is capable of carrying hundreds of fluorescent dye molecules in each FSNP, resulting in bright fluorescence. In FSNPs, fluorescent molecules are somewhat protected by the surrounding silica layer, resulting in good photostability. For cancer cell imaging, surface modification of FSNPs is often necessary to obtain appropriate surface functional groups to improve NP aqueous dispersibility as well as bioconjugation capability. Using conventional bioconjugate chemistry, cancer cell-specific biomolecules are then attached to the surface-modified FSNPs. For targeting cancer cells, the FSNPs are often conjugated to specific biomolecules such as antibodies, aptamers, and folic acid. In this chapter, different approaches for the FSNP design will be discussed and some representative protocols for FSNP synthesis will be provided. We will also discuss FSNP surface modification and bioconjugation techniques that are useful for cancer cell imaging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20217594     DOI: 10.1007/978-1-60761-609-2_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Synthesis of Hexagonal ZnO-PQ7 Nano Disks Conjugated with Folic Acid to Image MCF - 7 Cancer Cells.

Authors:  S Sureshkumar; B Jothimani; T M Sridhar; Arul Santhosh; B Venkatachalapathy
Journal:  J Fluoresc       Date:  2016-09-20       Impact factor: 2.217

2.  In vitro cytotoxicity of fluorescent silica nanoparticles hybridized with aggregation-induced emission luminogens for living cell imaging.

Authors:  Yun Xia; Min Li; Tao Peng; Weijie Zhang; Jun Xiong; Qinggang Hu; Zifang Song; Qichang Zheng
Journal:  Int J Mol Sci       Date:  2013-01-07       Impact factor: 5.923

Review 3.  Radiolabeled nanoparticles for multimodality tumor imaging.

Authors:  Yan Xing; Jinhua Zhao; Peter S Conti; Kai Chen
Journal:  Theranostics       Date:  2014-01-24       Impact factor: 11.556

Review 4.  Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.

Authors:  Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2014-03-28

5.  Fabrication of photoactive heterostructures based on quantum dots decorated with Au nanoparticles.

Authors:  Elisabetta Fanizza; Carmine Urso; R Maria Iacobazzi; Nicoletta Depalo; Michela Corricelli; Annamaria Panniello; Angela Agostiano; Nunzio Denora; Valentino Laquintana; Marinella Striccoli; M Lucia Curri
Journal:  Sci Technol Adv Mater       Date:  2016-04-12       Impact factor: 8.090

6.  Microwave plasma-assisted silicon nanoparticles: cytotoxic, molecular, and numerical responses against cancer cells.

Authors:  Rizwan Wahab; Farheen Khan; Anoop Gupta; Hartmut Wiggers; Quaiser Saquib; Mohammad Faisal; Sabiha Mahmood Ansari
Journal:  RSC Adv       Date:  2019-04-30       Impact factor: 4.036

Review 7.  Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Authors:  Rusdina Bte Ladju; Devis Pascut; Muhammad Nasrum Massi; Claudio Tiribelli; Caecilia H C Sukowati
Journal:  Oncotarget       Date:  2017-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.